Kibel, S.; Kuehne, N.; Ribeiro, M.F.; Muniz, T.P.; Ye, X.Y.; Spreafico, A.; Saibil, S.D.; Sun, A.; Mak, D.Y.; Gray, D.;
et al. The Role of Adjuvant Radiotherapy for the Treatment of Resected High-Risk Stage III Cutaneous Melanoma in the Era of Modern Systemic Therapies. Cancers 2023, 15, 5867.
https://doi.org/10.3390/cancers15245867
AMA Style
Kibel S, Kuehne N, Ribeiro MF, Muniz TP, Ye XY, Spreafico A, Saibil SD, Sun A, Mak DY, Gray D,
et al. The Role of Adjuvant Radiotherapy for the Treatment of Resected High-Risk Stage III Cutaneous Melanoma in the Era of Modern Systemic Therapies. Cancers. 2023; 15(24):5867.
https://doi.org/10.3390/cancers15245867
Chicago/Turabian Style
Kibel, Seth, Nathan Kuehne, Mauricio Fernando Ribeiro, Thiago P. Muniz, Xiang Y. Ye, Anna Spreafico, Samuel D. Saibil, Alexander Sun, David Y. Mak, Diana Gray,
and et al. 2023. "The Role of Adjuvant Radiotherapy for the Treatment of Resected High-Risk Stage III Cutaneous Melanoma in the Era of Modern Systemic Therapies" Cancers 15, no. 24: 5867.
https://doi.org/10.3390/cancers15245867
APA Style
Kibel, S., Kuehne, N., Ribeiro, M. F., Muniz, T. P., Ye, X. Y., Spreafico, A., Saibil, S. D., Sun, A., Mak, D. Y., Gray, D., Jones, B., Wong, P., & Butler, M. O.
(2023). The Role of Adjuvant Radiotherapy for the Treatment of Resected High-Risk Stage III Cutaneous Melanoma in the Era of Modern Systemic Therapies. Cancers, 15(24), 5867.
https://doi.org/10.3390/cancers15245867